GE-10 IDENTIFICATION OF PATIENTS WITH RECURRENT GBM THAT BENEFIT FROM BEVACIZUMAB

Por Eraslan, Lale Erdem, van den Bent, Martin, Kros, Johan, Oosterkamp, Hendrika, Walenkamp, Annemiek, Beerepoot, Laurens, Hanse, Monique, Buter, J., Honkoop, Aafke, van der Holt, Bronno, Vernhout, R.M., Smitt, Peter Sillevis, Taal, Walter, French, Pim
Publicado em 2014

AT-55 FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND F...

Por Taal, Walter, Enting, Roelien, Taphoorn, Martin, Smits, Marion, Dubbink, Hendrikus, Beerepoot, Laurens, Hanse, Monique, Bralten, Linda, Oosterkamp, Hendrika, Walenkamp, Annemiek, Buter, Jan, Honkoop, Aafke, Boerman, Dolf, de Vos, Filip, Bromberg, Jacoline, Vernhout, Rene, van der Holt, Bronno, van den Bent, Martin
Publicado em 2014